CD30, also known as TNFRSF8, is a cell surface protein belonging to the tumor necrosis factor receptor (TNFR) superfamily. It is primarily associated with certain types of lymphoid malignancies and is a significant biomarker in the field of histology. CD30 was first identified in the context of Hodgkin's lymphoma and is now utilized in various diagnostic and therapeutic applications.
